Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.
about
The potential impact of male circumcision on HIV in Sub-Saharan AfricaThe hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a reviewThe epidemiological impact of antiretroviral use predicted by mathematical models: a review.Modeling the impact of antiretroviral use in developing countriesWhich New Health Technologies Do We Need to Achieve an End to HIV/AIDS?Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009-2012) in an era of treatment as preventionWill HIV vaccination reshape HIV risk behavior networks? A social network analysis of drug users' anticipated risk compensationOperations research in global health: a scoping review with a focus on the themes of health equity and impactRelationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccinationModelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.Sexually transmitted infections among HIV-1-discordant couples.Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV.Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers.Dynamic mathematical models of HIV/AIDS transmission in China.The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling studyVariation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesisThe cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.Network effects of risk behavior change following prophylactic interventionsModelling sexual transmission of HIV: testing the assumptions, validating the predictions.Potential future impact of a partially effective HIV vaccine in a southern African setting.HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South AfricaModeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapyVaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, ChinaChanging risk behaviours and the HIV epidemic: a mathematical analysis in the context of treatment as prevention.Drug users' willingness to encourage social, sexual, and drug network members to receive an HIV vaccine: a social network analysisA systematic review of the quality of trials evaluating biomedical HIV prevention interventions shows that many lack power.Sexual risk taking among patients on antiretroviral therapy in an urban informal settlement in Kenya: a cross-sectional survey.AIDS vaccines and preexposure prophylaxis: is synergy possible?Individual-based simulation models of HIV transmission: reporting quality and recommendations.The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial resultsSexual behaviour of people living with HIV attending a tertiary care government hospital in Kathmandu, Nepal: a cross sectional study.HIV and SIV CTL escape: implications for vaccine design.Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.Discussion and revision of the mathematical modeling tool described in the previously published article "Modeling HIV Transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy"Impact of male circumcision on HIV risk compensation through the impediment of condom use in BotswanaRisk compensation: the Achilles' heel of innovations in HIV prevention?Human immunodeficiency virus (HIV) in developing countries.Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example.
P2860
Q21144704-510C97A5-0E28-4DCB-9B8D-DD57B974282AQ24630490-0984FEE5-BB94-4E8B-8CC6-F60BAAEFD80AQ24814633-A9C50D40-2A3D-44C0-8617-60D2804A828DQ25255741-B3C3E384-D750-460A-949B-29227358DFCAQ26765043-D3AA9885-AE39-49F4-A7BC-EE835352B803Q27023036-282BFC02-949F-457B-9833-19A1C7137E73Q28540319-382B8217-1F64-4CC5-AA40-CC5D7A499F83Q29994616-A1ACC289-A56F-4D2E-8733-B250E925D9D0Q30204590-9914A2E9-27EC-4AF6-98AB-D1C0ED700107Q33278148-AFA72A37-CF47-44D4-973D-258A86C1EC54Q33518566-DC2AD7B0-CFBA-4730-8B9E-DF0D9E074293Q33644290-019E8FD3-41C7-4914-A399-78F221378481Q33670446-BC0CA737-4B56-4E37-A227-8D1C06EE0255Q33786420-4358A185-B3B5-4779-95A6-B7B72F69BE35Q33924786-8F62A4B2-F837-44E3-A9D5-8BEBD3A77AE3Q33956748-B9E4457D-9B59-4679-ADC9-07EAFC085A55Q34007753-912F97BE-0341-4689-A58F-FBE6126A23DAQ34029513-2AECBED3-15AD-4A52-B462-E22ED0E2FAB9Q34037815-A5055D89-ADAD-457A-94E5-9E9217740768Q34071168-513827E5-2BDB-4FF9-BE8F-A433EF8D8542Q34160133-92C23C22-732A-45E0-8E0A-01F5949DE206Q34339465-5B781DB0-B7E8-4F10-A11D-A1FD7576DDEDQ34484127-D0C766DF-C3E0-4AB7-9359-9371FA4AE651Q34651604-1A076689-DAC1-45EE-B51A-BA7F4DF50A73Q34678219-3BA2D7AA-C3CF-4B2A-8C18-676F4C09A4AFQ34720561-A98784A1-C7EE-4B5B-9BEA-411940D9A25FQ34786117-794A7547-E291-43D6-AE26-3DE283079940Q34913280-24206B9A-F704-43B7-8842-A83DE6DC3A0EQ34961882-EF9A9B22-29E7-4F54-853C-C3112F8593FBQ35003539-5908E251-7615-411F-A351-22B7525DA4CEQ35010032-8575EAE1-5A73-4500-B6FF-F01D11651E59Q35187930-9668F0C1-41A4-441E-A12B-BE6D371F5590Q35829549-1BE47AB1-D0E4-4B22-ABB6-FA7A39638AE7Q35852284-A7C5233C-D5DE-4AAE-9469-E9C98D42CE12Q35928138-DA38EBAE-5FEF-42B7-AE0C-E64030713BE8Q35973913-2DE87F92-0D94-40FD-8B44-B7E175516B41Q35996956-2EABFC85-703E-4F7C-B81A-7A3C22F5D6A9Q36417699-3A982533-2AF2-4FD4-B65F-F3E9D163B826Q36561178-4457F67D-8845-4405-A4B5-1BE012E4EA38Q36603971-3DC0F823-F8F7-496B-99D6-A3939DEAE697
P2860
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@ast
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@en
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@nl
type
label
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@ast
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@en
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@nl
prefLabel
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@ast
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@en
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@nl
P2093
P50
P921
P1433
P1476
Stochastic simulation of the i ...... V transmission; Rakai, Uganda.
@en
P2093
Rakai Project Group
Richard Moore
Xianbin Li
P304
P356
10.1097/00002030-200309050-00013
P407
P50
P577
2003-09-01T00:00:00Z